The trial, which compared Retevmo to placebo, met its primary endpoint with a “highly statistically significant and clinically meaningful improvement” in investigator-assessed EFS for patients with stage II–IIIA disease
The FDA’s Center for Biologics Evaluation and Research (CBER) cited Moderna’s choice of a licensed standard-dose flu vaccine as the comparator in its Phase 3 trial, saying it “does not reflect the best-available standard of care.”
The facility is dedicated to breakthrough innovations in laboratory instruments that detect infectious diseases, cancer, and blood disorders
The supplements are made using only vegetarian-sourced ingredients
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
The interim efficacy readout, involving around 170 participants with 15-month data, remains on track for the end of March 2026
In 2024, 59 countries reported large or disruptive measles outbreaks – nearly triple the number reported in 2021 and the highest since the onset of the COVID-19 pandemic
The update reflects long-term clinical trial data showing that many patients with mCSCC or laCSCC experienced lasting responses
Owlet’s push comes as parents demand smarter, more dependable nursery tech
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
